UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Co-infection with SARS-CoV-2 and influenza A virus

IDCases, 2020-01, Vol.20, p.e00775, Article e00775

2020

Volltextzugriff (PDF)

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

Nature (London), 2009-08, Vol.460 (7258), p.1021-1025

2009

Volltextzugriff (PDF)

Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019

Emerging infectious diseases, 2019-11, Vol.25 (11), p.2108-2111

2019

Volltextzugriff (PDF)

Epidemiology of macrolide-resistant Mycoplasma pneumoniae by age distribution in Japan

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021-01, Vol.27 (1), p.45-48

2021

Volltextzugriff (PDF)

Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013–2016

Vaccine, 2018-02, Vol.36 (8), p.1063-1071

2018

Volltextzugriff (PDF)

Successful Elimination of SARS-CoV-2 Following Vaccination with BNT162b2 after Prolonged Viral Infection in an Immunocompromised Lymphoma Patient

Internal Medicine, 2022/07/15, Vol.61(14), pp.2215-2219

2022

Volltextzugriff (PDF)

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months

EClinicalMedicine, 2021-02, Vol.32, p.100734-100734, Article 100734

2021

Volltextzugriff (PDF)

Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018

Euro surveillance : bulletin européen sur les maladies transmissibles, 2019-01, Vol.24 (3), p.1

2019

Volltextzugriff (PDF)

Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effect

Japanese journal of radiology, 2022-08, Vol.40 (8), p.800-813

2022

Volltextzugriff (PDF)

Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan

Internal Medicine, 2022/06/01, Vol.61(11), pp.1681-1686

2022

Volltextzugriff (PDF)

Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season

Vaccine, 2018-09, Vol.36 (37), p.5510-5518

2018

Volltextzugriff (PDF)

Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022

Emerging infectious diseases, 2022-11, Vol.28 (11), p.2198-2205

2022

Volltextzugriff (PDF)

Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013–18

Vaccine, 2019-07, Vol.37 (30), p.4047-4054

2019

Volltextzugriff (PDF)

Clinical usefulness of a rapid molecular assay, ID NOW™ influenza A & B 2, in adults

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021-03, Vol.27 (3), p.450-454

2021

Volltextzugriff (PDF)

A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs

Viruses, 2022-03, Vol.14 (3), p.562

2022

Volltextzugriff (PDF)

Lower Clinical Effectiveness of Oseltamivir against Influenza B Contrasted with Influenza A Infection in Children

Clinical infectious diseases, 2007-01, Vol.44 (2), p.197-202

2007

Volltextzugriff (PDF)

Clinical evaluation of ID NOW influenza A & B 2, a rapid influenza virus detection kit using isothermal nucleic acid amplification technology - A comparison with currently available tests

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020-02, Vol.26 (2), p.216-221

2020

Volltextzugriff (PDF)

Enhanced Expression of an α2,6-Linked Sialic Acid on MDCK Cells Improves Isolation of Human Influenza Viruses and Evaluation of Their Sensitivity to a Neuraminidase Inhibitor

Journal of Clinical Microbiology, 2005-08, Vol.43 (8), p.4139-4146

2005

Volltextzugriff (PDF)

Clinical Evaluation of the Immunochromatographic System Using Silver Amplification for the Rapid Detection of Mycoplasma pneumoniae

Scientific reports, 2018-01, Vol.8 (1), p.1430-7, Article 1430

2018

Volltextzugriff (PDF)

Comparison of the Clinical Effectiveness of Oseltamivir and Zanamivir against Influenza Virus Infection in Children

Clinical infectious diseases, 2008-08, Vol.47 (3), p.339-345

2008

Volltextzugriff (PDF)

Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan

Euro surveillance : bulletin européen sur les maladies transmissibles, 2016-10, Vol.21 (42)

2016

Volltextzugriff (PDF)

Response to RMED-D-22–00,258.R1

Japanese journal of radiology, 2022-08, Vol.40 (8), p.860-861

2022

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Englisch
(122)
Japanisch
(60)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Co-infection with SARS-CoV-2 and influenza A virus

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019

Epidemiology of macrolide-resistant Mycoplasma pneumoniae by age distribution in Japan

Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013–2016

Successful Elimination of SARS-CoV-2 Following Vaccination with BNT162b2 after Prolonged Viral Infection in an Immunocompromised Lymphoma Patient

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months

Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018

Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effect

Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan

Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season

Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022

Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era

Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 season

Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013–18

Clinical usefulness of a rapid molecular assay, ID NOW™ influenza A & B 2, in adults

A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs

Lower Clinical Effectiveness of Oseltamivir against Influenza B Contrasted with Influenza A Infection in Children

Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results

Clinical evaluation of ID NOW influenza A & B 2, a rapid influenza virus detection kit using isothermal nucleic acid amplification technology - A comparison with currently available tests

Enhanced Expression of an α2,6-Linked Sialic Acid on MDCK Cells Improves Isolation of Human Influenza Viruses and Evaluation of Their Sensitivity to a Neuraminidase Inhibitor

Clinical Evaluation of the Immunochromatographic System Using Silver Amplification for the Rapid Detection of Mycoplasma pneumoniae

Comparison of the Clinical Effectiveness of Oseltamivir and Zanamivir against Influenza Virus Infection in Children

Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan

Response to RMED-D-22–00,258.R1

Suchergebnisse filtern